Abstract:Diffuse large B cell lymphoma (DLBCL) is one of the most usual types of adult lymphoma with heterogeneousness in histological morphology, prognosis, and clinical indications. Prior to this, several studies were carried out to determine the DLBCL subtype based on the analysis of the genome profile. However, classification based on assessment of genes related to the immune system has limited clinical significance for DLBCL. We systematically explored the DLBCL gene expression dataset and provided publicly available clinical information on patients with GEO. In this research, 928 DLBCL samples were applied, and we calculated 29 immune-related genomes' enrichment levels in each sample and stratified them into high immunity (Immunity_H, n = 135 , 28.7%), moderate immunity (Immunity_M, n = 135 , 28.7%), and low immunity (Immunity_L, n = 12 , 2.6%) that was based on ssGSEA score. The ESTIMATE algorithm was used to calculate stromal scores (range 586.88 to 1982.43), immune scores, estimated scores (range 2,618.2 to 8,098.14), and tumor purity (range 0.216 to 0.976). All of them were significantly correlated with immune subtypes (Kruskal-Wallis test, p < 0.001 ). At the same time, the correlation of related genes was analyzed by immunohistochemistry staining. In addition, DLBCL cells were cultured in transfected and in vitro with siRNA to verify correlation analysis and gene expression. Finally, human peripheral blood lymphocytes were incubated with DLBCL cells and stained. Flow cytometry was applied to analyze genes' influence on immune function. By analysis, immune checkpoint and HLA gene expression levels were higher in the Immunity_H group (Kruskal-Wallis test, p < 0.05 ). The levels of Tfhs (follicular helper T cells), monocytes, CD8+ T cells, M1 macrophages, M2 macrophages, and CD4+ memory-activated T cells were the most excellent in Immunity_H, and the total survival rate was higher in the Immunity_L. Through analysis, IRF4 (MUM1) was identified by us as immunotherapeutic target and a potential prognostic marker for DLBCL, which was made sure by using molecular biology experimentations. To conclude, immunosignature made a connection between DLBCL subtypes playing a position in DLBCL prognostic stratification. Immunocharacteristics-related DLBCL subtypes' construction predicts expected patient results and supplies conceivable immunotherapy candida.

[Analysis of Diffuse Large B-cell Lymphoma Heterogeneity Based on Coupled Two-Way Clustering].

Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering

Unraveling the hidden heterogeneities of breast cancer based on functional miRNA cluster.

Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma

Using Gene Ontology-based clustering method to study the genetic heterogeneity of leukemia

Identification of Hub Genes Associated with the Pathogenesis of Diffuse Large B-cell Lymphoma Subtype One Characterized by Host Response Via Integrated Bioinformatic Analyses.

Robust structured heterogeneity analysis approach for high-dimensional data

Heterogeneity Between Primary Colon Carcinoma and Paired Lymphatic and Hepatic Metastases.

Regression‐based heterogeneity analysis to identify overlapping subgroup structure in high‐dimensional data

A Robust Hybrid Approach Based on Estimation of Distribution Algorithm and Support Vector Machine for Hunting Candidate Disease Genes.

Peeling Off the Hidden Genetic Heterogeneities of Cancers Based on Disease-Relevant Functional Modules

Identification of two heterogeneous subtypes of hepatocellular carcinoma with distinct pathway activities and clinical outcomes based on gene set variation analysis

Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma

Integrative analysis of hub genes and key pathway in two subtypes of diffuse large B-cell lymphoma by bioinformatics and basic experiments

Robust Analysis of Cancer Heterogeneity for High‐dimensional Data

Cell Heterogeneity Analysis in Single-Cell RNA-seq Data Using Mixture Exponential Graph and Markov Random Field Model

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Single Cell Phenotypic Profiling of 27 DLBCL Cases Reveals Marked Intertumoral and Intratumoral Heterogeneity

Heterogeneity Analysis Via Integrating Multi-Sources High-Dimensional Data with Applications to Cancer Studies

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy